Global Immunoassay Market to Grow at 4.78% During 2025-2033, Impelled by the Increasing Prevalence of Chronic Diseases

January 22, 2025 | Healthcare

According to the latest report by IMARC Group, titled “Immunoassay Market Report by Technology (Radioimmunoassay, Enzyme Immunoassay, Rapid Test, and Others), Product (Reagents and Kits, Analyzers/Instruments, Software and Services), Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, and Others), End Use (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, and Others), and Region 2025-2033,” the global immunoassay market reached a value of USD 32.6 Billion in 2024. Immunoassay (IA) is a biochemical technique used to measure the concentration or presence of macromolecules analytes in a solution through an antibody or an antigen. The immunoassay instruments help in detecting the concentration and presence of analytes in the blood, plasma and urine samples. It plays a crucial role in clinical diagnostics, pharmaceutical analysis, environmental monitoring, and security and finds application in research centers, hospitals, and laboratories.

Global Immunoassay Market Trends:

The rising cases of infectious diseases around the world are driving the growth of the market. Immunoassay has become an important part of the diagnostic regime for diseases, such as COVID-19, dengue, hepatitis, HIV, malaria, and tuberculosis. In addition to this, technological advancements in the field of immunoassays offering expedited results with higher efficacy, detection limits, sensitivity, and cost-efficiency are contributing to the market growth. The increasing adoption of rapid tests and point-of-care (PoC) testing for drug monitoring and alcohol abuse is acting as another major growth-inducing factor. Furthermore, growth in biotechnology and biopharmaceutical industries coupled with the emerging trend of smartphone-based formats and multiplex bead assays are creating a positive outlook for the market. Looking forward, the market value is projected to reach USD 51.5 Billion by 2033, expanding at a CAGR of 4.78% during 2025-2033.


Market Summary:

  • On the basis of the technology, the market has been divided into radioimmunoassay, enzyme immunoassay, rapid test and others.
  • Based on the end use, the market has been classified into hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, academic research centers and others.
  • On the basis of the product, the market has been classified into reagents and kits, analyzers/instruments, software and services.
  • Based on the application, the market has been classified into therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, autoimmune diseases and others.
  • On a regional basis, the market has been spread across North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (the United Kingdom, Germany, France, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Abbott, Becton Dickinson and Company, BioMérieux SA, Danaher Corporation, Merck KGaA, PerkinElmer Inc, Quidel Corporation, Siemens Healthcare Pty Ltd (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific.


Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Technology, Product, Application, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott, Becton Dickinson and Company, BioMérieux SA, Danaher Corporation, Merck KGaA, PerkinElmer Inc, Quidel Corporation, Siemens Healthcare Pty Ltd (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Immunoassay Market to Grow at 4.78% During 2025-2033, Impelled by the Increasing Prevalence of Chronic Diseases
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials